Abstract
To determine the effect of glycemic control on linear growth in children with insulin-dependent diabetes mellitus type 1, we studied 82 patients (40 male, 42 female) over a 6-year period. The mean ±SD for age of onset and duration of IDDM were 7.3±3.9 years and 4.8±3.5 years, respectively. At each clinic visit, glycemic control was assessed by measuring glycosylated hemoglobin (GHb). For a total of 751 clinic visits, the mean ±SD for chronologic age and GHb were 11.5±3.8 years and 10.2%±2.3%, respectively. Good glycemic control was correlated with more frequent clinic visits (r=−0.219,P<0.05). Growth was assessed by determining both weight and height, which were normalized for age and sex by calculating Z scores using Hanes I reference data. Differences in Z score between clinic visits (ΔZ) were calculated for both weight and height to determine changes in — growth velocity. The mean Z scores for weight and height were not attenuated in type 1 children compared with healthy children (0.56±1.00 and 0.25±0.99, respectively). There was no correlation between either mean Z scores for weight or height and GHb. Moreover, regression analysis revealed no significant correlation between GHb levels and ΔZ for either weight or height. While a significant correlation was observed between ΔZ for weight and height (r=0.30,P<0.01), the relationship was not affected by glycemic control. Therefore, these data demonstrate that weight gain and growth rate do not seem to be significantly affected by glycemic control. This study also confirms that linear growth velocity is dependent on weight gain and suggests that in type 1 children, weight gain and level of growth-promoting hormones such as insulin-like growth factor-1 (IGF-1) are more important regulators of linear growth than glycemic control.
Similar content being viewed by others
References
Jackson RL, Kelly HG, Growth of children with diabetes mellitus in relationship of level of control of the disease. J Pediatr 29:316–328, 1946
Malone JI, Lowett S, Duncan JA, Shah SC, Vargas A, Root AW, Hypercalciuria, hyperphosphaturia, and growth retardation in children with diabetes mellitus. Pediatrics 79:298–304, 1986
Wise JE, Kolb EL, Sanders ES, Effect of glycemic control on growth velocity in children with IDDM. Diabetes Care 15: 826–830, 1992
Hindmarsh PC, Matthews DR, Di Silvio L, Kurtz AB, Brook CGD, Relation between height velocity and fasting insulin concentrations. Arch Dis Child 63:665–666, 1988
Saladi S, Toniloni S, Tassoni P, Tellarini M, Mazzanti L, Cacciani E, Growth and growth factors in diabetes mellitus. Arch Dis Child 62:57–62, 1987
Evans N, Robinson VP, Lister J, Growth and bone age of juvenile diabetes. Arch Dis Child 47:589–593, 1972
Jivani SKM, Rayner PH, Does control influence the growth of diabetes children? Arch Dis Child 48:109–115, 1973
Herber SM, Dunsmore IR, Does control affect growth in diabetes mellitus? Acta Pediatric Scand 77:303–305, 1988
Craig JO, Growth as a measurement of control in the management of diabetic children. Postgrad Med J 46:607–610, 1970
Birkbeck JA, Growth in juvenile diabetes mellitus. Diabetologia 8:221–224, 1972
Clarson C, Daneman D, Ehrlich RM, The relationship of metabolic control to growth and pubertal onset in children with insulin dependent diabetes. Diabetes Res 2:237–241, 1985
National Center for Health Statistics, NCHS growth curves for children (birth-18 years). United States Vital and Health Statistics Series 11, Number 165
Zar JH, Biostatistical analysis, 2nd edn. Prentice-Hall, Englewood Cliffs
Lifshitz F, Nutrition and growth. In: Paige DM (ed) Clinical nutrition. (Nutrition and growth supplement, Vol 4). Mosby, St. Louis, pp 40–47, 1985
Lifshitz F, Moses N, Cervantes C, Ginsberg L, Nutritional dwarfing in adolescents. Semin Adolesc Med 3:255–256, 1987
Pugliese MT, Lifshitz F, Grad G, Marks-Katz M, Fear of obesity: a cause of short stature and delayed puberty. N Engl J Med 309:513–518, 1983
Kirschner BS, Growth retardation in Crohn's disease: the merits of aggressive nutritional therapy. Clin Nutr 2:26–28, 1983
Rosenfeld RG, Wilson DM, Dollar LA, Bennett A, Hintz RE, Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at postreceptor size. J Clin Endocrinol Metab 54:1033–1038, 1982
Diabetes Control and Complication Trial Research Group, Effect of intensive diabetes treatment on the development and progression of long-term complication in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 125:177–188, 1994
Van Wyk JJ, Underwood LE, The somatomedins and their actions. Biochem Actions Horm 5:101–148, 1978
Rudoff MCJ, Sherwin RS, Markowitz R, Bates SE, Genel M, Hochstadt J, Tamborlane WV, Effect of intensive insulin therapy on linear growth in the young diabetic patient. J Pediatr 101:333–339, 1982
Holly JMP, Dunger DB, Edge JA, Smith CP, Chard T, Wass JM, Insulin-like growth factor binding protein-I levels in diabetic adolescents and their relationship to metabolic control. Diabetic Med 7:618–623, 1990
Salardi S, Cacciari E, Ballardine D, Righetti F, Capelli M, Cicognani A, Zucchini S, Natali G, Tassinar D, Relationships between growth factors (somatomedin-C and growth hormone) and body development, metabolic control, and retinal changes in children and adolescents with IDDM. Diabetes 35:832–836, 1986
Blethen SL, Sargeant DT, Whitlow MG, Santiago JV, Effect of pubertal stage and recent blood glucose control on plasma somatomedin-C in children with insulin-dependent diabetes mellitus. Diabetes 30:868–872, 1981
Tamborlane WV, Hitz RL, Bergman M, Genel M, Felig P, Sherwin RP, Insulin-infusion pump treatment of diabetes: influence of improved control on plasma somatomedin levels. N Engl J Med 305:303–307, 1981
Horner JM, Kemp SF, Hintz RL, Growth hormone and somatomedin in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 53:1148–1153, 1981
Amiel SA, Sherwin RS, Hitz RL, Gertner JM, Press M, Tamborlane WV, Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 33:1175–1179, 1984
Taylor AM, Dunger DB, Preece MA, Holly JMP, Smith CP, Wass JM, Patel S, Tate VE, The growth hormone independent insulin like growth factor-I binding protein BP-28 in association with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetes. Clin Endocrinol 32: 229–239, 1990
Merimee TJ, Gardner DF, Zapf J, Froesch E, Effect of glycemic control on serum insulin-like growth factors in diabetes mellitus. Diabetes 33:790–793, 1984
Van Den Brande JL, Van Buul S, Heinrich U, Van Roon F, Zurcher T, Van Steirtegem AC, Further observations on plasma somatomedin activity in children. In: Luft R, Hall K (eds) Somatomedins and some other growth factors. (Adv Metab Disorders, Vol 8) Academic Press, New York, pp 171–181, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pitukcheewanont, P., Alemzadeh, R., Jacobs, W.R. et al. Does glycemic control affect growth velocity in children with insulin-dependent diabetes mellitus. Acta Diabetol 32, 148–152 (1995). https://doi.org/10.1007/BF00838483
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00838483